Vivet Therapeutics

Paris, France

Vivet Therapeutics is a biotechnology company developing gene therapy treatments for orphan diseases.

$5.3M raised

Feb 2024

Grant

Biopharma Biotechnology Health Care

Top Investors

Pfizer Kurma Partners Eurazeo HealthCap Columbus Venture Partners

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Vivet Therapeutics

How much funding has Vivet Therapeutics raised?

Vivet Therapeutics has raised $5.3M in total funding. The most recent round was Grant. The last funding was announced in February 2024.

Who are Vivet Therapeutics's investors?

Vivet Therapeutics's investors include Pfizer, Kurma Partners, Eurazeo, HealthCap, Columbus Venture Partners.

Where is Vivet Therapeutics headquartered?

Vivet Therapeutics is headquartered in Paris, France.

What does Vivet Therapeutics do?

Vivet Therapeutics is a biotechnology company developing gene therapy treatments for orphan diseases.

What stage is Vivet Therapeutics at?

Vivet Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 1, 2024.

MLA

"Vivet Therapeutics — Funding & Investors." VCBacked, February 1, 2024, https://www.vcbacked.co/company/vivet-therapeutics. Accessed July 4, 2026.

APA

VCBacked. (2024). Vivet Therapeutics — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/vivet-therapeutics

Wikipedia (cite web)

{{cite web |title=Vivet Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/vivet-therapeutics |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 1, 2024.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.